Cell Biology Unit, Institut de Genetique Humaine, UPR 1142 CNRS, 141 rue de la Cardonille, F34396 Montpellier Cedex 05, France.
Biochimie. 2013 Jul;95(7):1450-61. doi: 10.1016/j.biochi.2013.03.011. Epub 2013 Apr 6.
We describe a reliable and efficient method for the purification of catalytically active and mutant inactive full-length forms of the human dual specificity phosphatase cdc25C from bacteria. The protocol involves isolating insoluble cdc25C protein in inclusion bodies, solubilization in guanidine HCL, and renaturation through rapid dilution into low salt buffer. After binding renatured proteins to an ion exchange resin, cdc25C elutes in two peaks at 350 and 450 mM NaCl. Analysis by gel exclusion chromatography and enzymatic assays reveals the highest phosphatase activity is associated with the 350 mM NaCl with little or no activity present in the 450 mM peak. Furthermore, active cdc25C has a native molecular mass of 220 kDa consistent with a potential tetrameric complex of the 55-kDa cdc25C protein. Assaying phosphatase activity against artificial substrates pNPP and 3-OMFP reveals a 220 kDa form of the phosphatase is active in a non-phosphorylated state. The protein effectively activates cdk1/cyclin B prokinase complexes in vitro in the absence of cdk1 kinase activity in an orthovanadate sensitive manner but is inactivated by A-kinase phosphorylation. In vitro phosphorylation of purified cdc25C by cdk1/cyclin B1, cdk2/cyclin A2 and cdk2/cyclin E shows that distinct TP/SP mitotic phosphorylation sites on cdc25C are differentially phosphorylated by these 3 cdk/cyclin complexes associated with different levels of cdc25C activation. Finally, we show that endogenous native cdc25C from human cells is present in high molecular weight complexes with other proteins and resolves mostly above 200-kDa. These data show that untagged cdc25C can be purified with a simple protocol as an active dual specificity phosphatase with a native molecular mass consistent with a homo-tetrameric configuration.
我们描述了一种从细菌中纯化人源双特异性磷酸酶 cdc25C 全长催化活性形式和突变失活形式的可靠且高效的方法。该方案涉及将不溶性 cdc25C 蛋白沉淀在包涵体中,在盐酸胍中溶解,并通过快速稀释到低盐缓冲液中进行复性。将复性后的蛋白结合到离子交换树脂上后,cdc25C 在 350 和 450 mM NaCl 处洗脱为两个峰。凝胶排阻色谱和酶活性分析表明,最高的磷酸酶活性与 350 mM NaCl 相关,而在 450 mM 峰中几乎没有或没有活性。此外,活性 cdc25C 的天然分子量为 220 kDa,与 55 kDa cdc25C 蛋白的潜在四聚体复合物一致。用人工底物 pNPP 和 3-OMFP 测定磷酸酶活性表明,磷酸酶的 220 kDa 形式在非磷酸化状态下具有活性。该蛋白在没有 cdkl 激酶活性的情况下以 orthovanadate 敏感的方式有效地在体外激活 cdk1/cyclin B 原激酶复合物,但被 A-激酶磷酸化失活。cdkl/cyclin B1、cdk2/cyclin A2 和 cdk2/cyclin E 对纯化的 cdc25C 的体外磷酸化表明,cdc25C 上的不同 TP/SP 有丝分裂磷酸化位点被与不同水平的 cdc25C 激活相关的这 3 个 cdkl/cyclin 复合物以不同的方式磷酸化。最后,我们表明,来自人类细胞的内源性天然 cdc25C 与其他蛋白质一起存在于高分子量复合物中,主要在 200 kDa 以上。这些数据表明,未标记的 cdc25C 可以通过简单的方案进行纯化,作为具有与同源四聚体构象一致的天然分子量的活性双特异性磷酸酶。